Interims end of September: "The Company extended the SG016 Phase II trial to include a further 120 patients with confirmed COVID-19 to be dosed in the home environment (ongoing)"
"ONGOING". What on earth is going on? Why isn't this working?
Hi Basscadet. I normally reckon on you understanding the tech much better than me. I just look at the RNS carefully and try to get my head round it.
I have mentioned Silex about once every 9 months because the licence income to them from us could be very substantial relative to their size. The FT has their income at AU$1m, and that probably includes our US$400,000 last March. Net income minus AU$7.81. I bought in at AU$0.17, so at AU$0.56 today I'm happy - but not selling. [It is volatile, well back from its good news peak of 0.78 or more. They have 2 other technologies under their control and with potentially much larger markets: a laser tech for refining uranium (in process of commercialisation), and zero spin silicon for quantum computing - a market projected to be worth $50bn by 2040. The latter has Ozzie government funding and the "Potential to generate initial revenues under off-take agreement with SQC from 2023....High value, low volume market scenario in early years of production – minimal capex requirements". http://www.silex.com.au/getattachment/d57ac1a9-8c1b-4f35-89b2-ec648ea5596e/10-SLX-2020-AGM-Presentation-2020-10-15.pdf.aspx?ext=.pdf Don't mean to ramp another company here, but they are our partners not competitors, it's always good to know where our partners are at, and - yuh - it's been good to me, and anyone who bought in when I first mentioned it. As much by luck as judgement: the zero spin silicon bump up was completely unforeseen. They seem to have some good boffins.]
As ever I am in very deep with IQE.
This is the 2nd set of very significant new product news in just 10 days.
Both now out with customers for trials/sampling.
Both potentially generating major revenues (though they strangely give no indication of how major with either).
When's the penny going to drop? I mean rise.
Yes, more good news. Well written RNS, given the subject matter. Would have been helpful though if they had stated the size of the potential market, which I have the impression is huge, if this applies to all filters. ["more than half the value of front-end modules in handsets, an amount that is forecast to steadily increase with the onset of 5G connected devices according to industry analysts Yole Developpment (June 2018)" according to a very useful RNS from April 2019 https://www.lse.co.uk/rns/IQE/iqe-unveils-advanced-rf-filter-materials-portfolio-21u686bg2j9322f.html ]. Seems to me they have become very careful about blowing the trumpet. I wonder why?
It's based on the the cREO tech, which as you say is patented: bought from Translucent [parent company Australian 'Silex Systems', which has done well for me], and who get a 3% plus royalty, min US$400,00pa [small company, for them it's a LOT].
http://www.silex.com.au/cREO%E2%84%A2-Technology
"Silex subsidiary Translucent Inc developed a novel set of semiconductor materials known as ‘crystalline Rare Earth Oxides’ (cREO™) for application to the manufacturing of advanced semiconductor devices (such as wireless and optical communications) which use high performance compound semiconductor materials rather than silicon. The cREO™ technology is a potentially enabling technology that could create a step change in the integration of various compound semiconductor devices with large scale silicon wafer-based production techniques. This has the potential to improve performance and lower the cost of production of compound semiconductor devices such as chips for wireless communications equipment and power electronics devices.
The cREO™ technology was purchased by UK-based IQE (AIM: IQE) in early 2018 in accordance with the 2015 License and Assignment Agreement between Translucent and IQE. As a result, payment of US$5 million was received in September 2018 (in IQE stock). In addition, a perpetual royalty of at least 3% will be payable to Translucent on the sale of any IQE products that utilise the cREO™ technology. The agreement also provides for the payment of annual minimum royalties over the period 2019 to 2024, with the first minimum royalty of US$400,000 paid to Translucent in March 2020.
The cREO™ technology was successfully transferred in late 2015 to IQE’s Greensboro, North Carolina manufacturing facility for the continuation of product development and commercialisation activities. IQE continues to progress the development of cREO™ based high frequency filters for 5G handset applications."
"IQepiMo™ templates are available in diameters of up to 200 mm and trials are underway with potential customers and partners". Looks like the commercialisation of cREO is finally underway. Money?! :) But they keep it very quiet: what is the size of this market?
For me it's fortunate that it's pulled back, so I could get in at 93.6p. I've held this share in the past, a long time back, then sold but kept an eye on it. See my posts I do have my concerns, but have always wanted to be in here and think they may now be getting their act together. Shouldn't have attachments, but there will always be something about wood - and since that's not just true for me AXS has something special going for it. I would, however, really like to know if I was right in 2018 and they did buy Diamond Wood.
I don't know one end of an accounts report from the other, but I would dearly love to know WHAT THAT "GOODWILL IMPAIRMENT" WAS ABOUT. £25m is a lot of money to just disappear into thin air. Explanation needed.
Without it, if I understand things right (probably not) the loss would have been £2.5m: less than half the 5.21 from the year before, and continuing a steady progression towards profitability.
Unless it's changed the half year ends on 31st October. I suppose it's too much from this blank wall to expect a trading update next week, but last year the interim results RNS was mid-December.
If I wasn't too far in already I would be topping up. We may even be in the black.
Guys and girls, I'm looking for a way into robotics, and am way overweight here. The 2019 results never mention robotics, not once, but I would guess that LIDAR & 3D sensing are actually a major play on this - but I'm really ignorant here. Any thoughts?
Aixtron in Germany supply our MOCVD machines. My biggest faller today, but they report a 9 month 39% order increase as follows:
"AIXTRON SE (FSE: AIXA) got off to a successful start in the second half of 2020. Above all, the high demand from the application markets of gallium nitride power electronics and laser technology for optical data transmission and for 3D sensor technology enabled strong business development in the third quarter.
AIXTRON SE, one of the world's leading providers of deposition systems for the semiconductor industry, acquired orders with a volume of EUR 209.3 million from January 1 to September 30 . The special equipment manufacturer has thus increased the order volume in the corresponding period of the previous year by 39%."
https://www.aixtron.com/de/presse/presseinformationen/AIXTRON%20im%20Jahresendspurt%20/%20Deutlich%20h%C3%B6here%20Wachstumsdynamik%20im%20dritten%20Quartal%20/%20Kr%C3%A4ftiges%20Auftragsplus%20von%2039%25%20/%20Weiter%20gestiegene%20Umsatzdynamik%20/%20Unver%C3%A4ndert%20hohe%20F%26E-Aktivit%C3%A4ten%20/%20Progno_n1584
If that comes up in German you can go into English on the homepage. Seems to me any alternative technologies are way behind for now? I wonder if IQE has been buying.
There is a big backlog in supply, increased by 51%, and it takes a long time (and a lot of expertise I think) to get them producing to the necessary standard once on site. IQE is up and running and has decades worth of that expertise.
If I can find some money maybe I'll top them up, but do you agree it bodes well for us?
PS The 2015 to 2020 agreement with Solvay would have given them just the time period to build and commission their own planned 63,000 cubic metre plant, meanwhile through the offtake agreement building market share in their exclusive European territories. It looks to me like AXS and Solvay agreed to split Europe between them but I have no expertise in these things and may be completely barking up the wrong tree. Does anyone with more expertise and experience get this thing better than I do?
The 1st post on this board! 7th June 07: "Accsys is in this weeks Shares magazine in the cover story 25 Best Aim shares"
Cover story in '07! A few years later spindok was saying "We need a ramper!" Love that comment. Is the post still vacant??
I sold out, very unhappily, 5 years ago, very concerned about opacity and what we were not being told. I thought, and still think, they were hiding a ginormous mess up - probably with licences, worldwide. They lost a case against Diamond Wood China and had the costs awarded against them, and I had questions in the same area about their agreements with Solvay in Europe (RNS 26 November 2015).
"Solvay will purchase a minimum 76,000 cubic metres of Accoya from the Arnhem plant over the period from 2016 to 2020 (the "offtake commitment") and as a result of the increased manufacturing capacity in Arnhem and consequent greater sales capacity, under the new agreement Solvay will review the optimal timing to construct its 63,000 cubic metres Accoya manufacturing plant."
"The licence agreement covering Europe has been amended to provide increased royalties to Accsys and the return to Accsys of the selling rights for 20 European countries."
Had they reached an impasse and Solvay agreed some kind of deal to split the pie and to hold fire on its plant? "Accsys will provide sales and marketing services to Solvay on agreed terms in respect of Solvay's exclusive European territories." It is - above - SOLVAY'S 63,000 manufacturing plant whose construction was to be reviewed, and they have exclusive European territories.
NB the offtake agreement ends this year, 2020 - but it doesn't give an exact date. So might our revenue drop off??
In March 2018 I was under the impression they had bought Diamond Wood China, but I can't see where I got that from. Anyone spot it? That would be important because under the judgement from 2014 the licence was to continue: "In July the Company reported that the Tribunal delivered a ruling (the 'Ruling') that, in response to Diamond Wood's claim for damages in excess of €100 million, Diamond Wood can only claim for limited damages, if any, up to a maximum of €250,000. However, the Tribunal also ruled that the licence agreement between the two parties is to continue. The Tribunal has now issued a final award in respect of costs relating to the Ruling which are payable to Diamond Wood, being approximately £1.6m."
Well, I've talked myself out of spindok's job offer! But actually I'm now interested in getting back in, in spite of the concerns above. One way or another they appear to be sorting themselves out. Still opaquely, to my mind. But there is product, demand, capacity coming online, and there simply must be a way to market now or they wouldn't be doing what they are doing. But I'd love to know the actual story.
Big jump today, for no apparent reason. Hoping for my sake it pulls back so I can get in. ATB, all. Hope all this info is useful.
Pardon me, finally found it: a product of Celare, "CELARE established in May 2012 as a subsidiary of BATM group. BATM develops and manufactures network switching and routing equipment and systems for the last 20 years targeted mainly for Telecom, utilities and defense markets. BATM offers its customers a diversified array of innovative high speed network access and solutions.
CELARE is the Cyber arm of BATM bringing DPI based network perimeter monitoring solutions with integrated Big Data security analytics and threat detection, helping security professionals to better visibility of their networks."
https://celarenet.com/?page_id=122